Beneficial effects of a serine protease inhibitor in peripheral vascular disease
- 1 July 1993
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 72 (2) , 218-222
- https://doi.org/10.1016/0002-9149(93)90163-7
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Role of locally formed angiotensin II and bradykinin in the reduction of myocardial infarct size in dogsCardiovascular Research, 1993
- Contribution of Splanchnic and Peripheral Vascular Tissues to the Disposal of Angiotensin-II and to Regional Conversion Rates of Angiotensin-IJournal of Cardiovascular Pharmacology, 1991
- Plasma Concentrations of Endothelin-1 and Endothelin-3 Are Altered Differently in Various Pathophysiological ConditionsJournal of Cardiovascular Pharmacology, 1991
- Characterization of endothelin converting enzyme activities in soluble fraction of bovine cultured endothelial cellsBiochemical and Biophysical Research Communications, 1990
- Influence of peripheral arterial occlusive disease on muscular metabolismJournal of Molecular Medicine, 1989
- Effects of Clinostatism and Orthostatism on Blood ViscosityInternational Journal of Sports Medicine, 1989
- Direct formation of angiotensin II without renin or converting enzyme in the ischemic dog heart.Japanese Heart Journal, 1989
- A human neutrophil-dependent pathway for generation of angiotensin II. Purification of the product and identification as angiotensin II.Journal of Clinical Investigation, 1981
- Effects of exercise on plasma viscosity in athletes and sedentary normal subjectsClinical Cardiology, 1981
- Ability of kallikrein to generate angiotensin II-like pressor substance and a proposed ‘kinin–tensin enzyme system’Nature, 1980